This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Can the Economy Come Out of Coronavirus-Induced Ventilation?
by Supriyo Bose
With a likely pent-up demand resulting from a prolonged period of low activities, the economy is expected to rebound stronger once the virus dies out.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - April 02, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
CVS Health (CVS) Stock Moves -0.5%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $59.38, marking a -0.5% move from the previous day.
Cigna (CI) Ramps up Efforts to Contain Coronavirus Spread
by Zacks Equity Research
Cigna (CI) actively expands service suite for customers, thereby, helping contain the virus spread.
Buy Walgreens (WBA) Stock Ahead of its Q2 Fiscal 2020 Earnings Release?
by Benjamin Rains
Should investors think about buying Walgreens stock with the pharmacy and retail giant set to report its Q2 fiscal 2020 earnings results on Thursday, April 2?
3 Top Dividend Stocks to Maximize Your Retirement Income - March 26, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $53.64 in the latest trading session, marking a -1.31% move from the prior day.
UnitedHealth's Unit Expands Services Amid Coronavirus Outbreak
by Sapna Bagaria
UnitedHealth's (UNH) UnitedHealthcare business actively enhances service suites for customers, thereby helping contain the virus spread.
4 Stocks Bucking the Layoff Trend Amid Coronavirus Scare
by Suranjana Roy
COVID-19 is taking an enormous toll on economic and health infrastructure, thereby resulting in massive layoffs. However, there are certain companies that are challenging this downtrend.
Dollar General (DG) Ramps Up Hiring Amid Coronavirus Crisis
by Zacks Equity Research
In the wake of coronavirus outbreak, Dollar General (DG) plans to hire roughly 50,000 workers by April end to support customers.
6 Stocks in Focus on Hiring Spree Despite Market Turmoil
by Nalak Das
Several retail stores, including supermarkets, grocery chains, medical and pharmacy stores, take-away restaurants and e-commerce companies are hiring people.
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, BHP, CVS Health, T-Mobile US and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, BHP, CVS Health, T-Mobile US and Anthem
Top Research Reports for Bristol-Myers, BHP & CVS
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers Squibb (BMY), BHP Group (BHP) and CVS Health (CVS).
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - March 20, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
3 High-Yield REITs for Income Investors to Buy to Fight Coronavirus Volatility
by Benjamin Rains
Now, let's dive into three high-yield REITs that investors might want to buy to help add income amid the coronavirus market downturn...
Retirees Should Know These 3 Facts About Required Minimum Distributions - March 19, 2020
by Zacks Equity Research
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
CVS Health (CVS) Stock Moves -1.41%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $57.18 in the latest trading session, marking a -1.41% move from the prior day.
Teladoc Witnesses Higher Visits Due to Coronavirus Outbreak
by Zacks Equity Research
Teladoc's (TDOC) teleheath services are witnessing increase in demand due to coronavirus outbreak.
CVS Health (CVS) Down 24.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - March 13, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
CVS Health's Schnuck Pharmacy Buyout to Widen Specialty Arm
by Zacks Equity Research
Given the growing prospects of specialty pharmacy, CVS Health (CVS) is prioritizing expansion of this business.
CVS Health's Latest Alliances to Fortify Kidney-Care Business
by Zacks Equity Research
With a growing incidence of chronic kidney diseases and end-stage renal failure in the United States, CVS Health's (CVS) new partnerships seem to be strategic.
Can Telemedicine be a Market Savior on Rising Corona Scare?
by Urmimala Biswas
Here are four telemedicine stocks which have robust prospects to become attractive picks on the COVID-19 economic doldrums.
3 Top Dividend Stocks to Maximize Your Retirement Income - March 03, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
3 Top Dividend Stocks to Maximize Your Retirement Income - February 26, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.